Mosaic ImmunoEngineering, Inc. (CPMV)
OTCMKTS · Delayed Price · Currency is USD
0.9980
-0.0520 (-4.95%)
Oct 20, 2025, 3:36 PM EDT
Mosaic ImmunoEngineering Market Cap
Mosaic ImmunoEngineering has a market cap or net worth of $7.23 million as of October 21, 2025. Its market cap has increased by 21.56% in one year.
Market Cap
7.23M
Enterprise Value
8.80M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.00
Market Cap Chart
Since October 15, 2020, Mosaic ImmunoEngineering's market cap has increased from 1.69M to 7.23M, an increase of 328.72%. That is a compound annual growth rate of 33.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2025 | 7.23M | 42.33% |
| Dec 31, 2024 | 5.08M | 16.87% |
| Dec 29, 2023 | 4.35M | -39.39% |
| Dec 30, 2022 | 7.17M | -2.75% |
| Dec 31, 2021 | 7.37M | 181.52% |
| Dec 31, 2020 | 2.62M | 55.34% |
| Oct 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 671.98M |
| Elite Pharmaceuticals | 660.18M |
| Veradigm | 517.28M |
| Northwest Biotherapeutics | 347.69M |
| CytoDyn | 336.10M |
| Nika Pharmaceuticals | 333.67M |
| Silence Therapeutics | 307.02M |
| American Oncology Network | 277.57M |